Safety data sheet. GHS / OSHA HCS 2012 format, 16 sections. Issued by Epic Peptides Lab for the catalogue items listed in Section 1.

Epic Peptides Lab

Safety data sheet · solution, metered nasal spray

Epic Peptides Lab · USA

Document number: PL-SDS-035
Revision: 1.0 · 2026-10-03

Cerebrolysin

solution, metered nasal spray

1Identification

Product Identifier

Cerebrolysin

Document Number

PL-SDS-035

Catalogue Items Covered

Id
15850
Name
Cerebrolysin 120mg Nasal Spray
Sku
PL-CEREBROLYSIN-120MG-NS

Recommended Use

Laboratory research use by trained personnel.

Restrictions On Use

Not for human or veterinary use.

Supplier / Distributor

Epic Peptides Lab, USA

Telephone

+1 (787) 468-5291

info@epicpeptideslab.com

2Hazard(s) identification

Classification: Not classified as hazardous under OSHA HCS 2012 (29 CFR 1910.1200) or UN GHS, on the basis of the supplier safety data sheets consulted.
Label Elements: No data available.
Signal Word: No data available.
Other Hazards: No data available.

3Composition / information on ingredients

Description

Sterile aqueous solution in bacteriostatic water (0.9% benzyl alcohol), supplied in a metered-dose nasal spray bottle.

Composition

Name
Cerebrolysin
Full
Porcine brain peptide hydrolysate; a peptide preparation, not a single compound
Cas
12656-61-0
Formula
Not applicable (mixture)
Conc
≤ 1.2% w/v
Qty
120 mg per bottle
Name
Benzyl alcohol (preservative)
Full
Benzyl alcohol, antimicrobial preservative (0.9% w/v in bacteriostatic water)
Cas
100-51-6
Formula
C7H8O
Conc
0.9% w/v
Hazards
- Acute toxicity, oral — Category 4 — H302
- Acute toxicity, inhalation — Category 4 — H332
- Serious eye damage/eye irritation — Category 2A — H319
- Skin sensitisation — Category 1B — H317
Name
Water for injection
Full
Water for injection
Cas
7732-18-5
Formula
H2O
Conc
balance to 100%

4First-aid measures

First Aid Measures

Inhalation: Move the person to fresh air and keep comfortable for breathing. If breathing is difficult or symptoms persist, call a POISON CENTER or doctor.
Skin: Take off contaminated clothing. Wash the skin with plenty of soap and water. If irritation or a rash develops, get medical advice.
Eyes: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do; continue rinsing. If eye irritation persists, get medical advice.
Ingestion: Rinse mouth. Do not induce vomiting. Call a POISON CENTER or doctor if you feel unwell.
Injection: For an accidental needle-stick: wash the site with soap and water, do not squeeze, cover with a dressing and seek medical advice; report the incident according to your laboratory's sharps procedure.

Most Important Symptoms And Effects

No specific symptoms are known. Pharmacologically active material: systemic effects consistent with its mechanism of action are possible after accidental injection, ingestion or absorption.

Likely Routes Of Exposure

Inhalation of the aerosol and absorption through the nasal mucosa are the intended laboratory routes; eye contact from mis-directed spray; skin contact.

5Fire-fighting measures

Fire Fighting Information: Aqueous solution containing 0.9% benzyl alcohol; not flammable and does not support combustion.

6Accidental release measures

Spill And Clean Up Procedures: Absorb small spills with paper towel or an inert absorbent, place in a sealed container for disposal and clean the area with water and detergent.

7Handling and storage

Safe Handling: Avoid spraying toward the eyes or face. Do not share devices. Wipe the nozzle after use and keep the cap on. Wash hands after handling.
Safe Storage: Store at 2–8 °C, protected from light; do not freeze. Keep upright and capped.
Storage Temperature: 2–8 °C, protected from light; do not freeze
Incompatible Materials: Strong oxidizing agents, strong acids/bases

8Exposure controls / personal protection

Occupational Exposure Limits: Benzyl alcohol: no OSHA PEL, ACGIH TLV or NIOSH REL; AIHA WEEL 10 ppm (44 mg/m³) 8-h TWA. Present at 0.9%.

No occupational exposure limits have been established for the active ingredient(s).
Exposure Controls And PPE: No data available.

9Physical and chemical properties

Physical State

Liquid

Appearance

Clear, colourless to faintly yellow aqueous solution

Properties

Odor: Odourless to faint aromatic odour (benzyl alcohol)
Ph: Approximately 4.5–7.0 (bacteriostatic water, USP) unless adjusted
Melting: About 0 °C (aqueous solution)
Boiling: About 100 °C (aqueous solution)
Flash: Not flammable; aqueous solution (benzyl alcohol flash point 93–101 °C, present at 0.9%)
Vapour: As water (about 2.3 kPa at 20 °C)
Density: About 1.00–1.02 g/mL at 20 °C
Solubility: Aqueous solution; miscible with water
Logp: Not applicable
Decomp: Not applicable (aqueous solution); dissolved peptide degrades on heating

10Stability and reactivity

Stability And Reactivity

Reactivity: Stable when stored 2-8 °C protected from light; no dangerous reactions known
Incompatible: Strong oxidizing agents, strong acids/bases
Decomposition: Combustion: carbon oxides, nitrogen oxides, sulfur oxides
Conditions To Avoid: Heat, light, microbial contamination; do not freeze solutions

Conditions To Avoid

Heat, light, microbial contamination; do not freeze solutions

Incompatible Materials

No data available.

11Toxicological information

Toxicological Information: Acute toxicity, oral
No data available

Acute toxicity, dermal
No data available

Acute toxicity, inhalation
No data available

Skin corrosion/irritation
No data available

Serious eye damage/irritation
No data available

Respiratory or skin sensitisation
Clinical hypersensitivity reactions to the injected drug are documented (contraindicated in hypersensitivity to components); animal-derived protein hydrolysate powders can be respiratory/skin sensitisers (H334/H317 consideration)

Germ cell mutagenicity
No data available

Carcinogenicity
Not listed by IARC, NTP, OSHA

Reproductive toxicity
No data available

STOT, single exposure
No data available

STOT, repeated exposure
No data available

Aspiration hazard
No data available
Routes Of Exposure: Inhalation of the aerosol and absorption through the nasal mucosa are the intended laboratory routes; eye contact from mis-directed spray; skin contact.
Symptoms: No specific symptoms are known. Pharmacologically active material: systemic effects consistent with its mechanism of action are possible after accidental injection, ingestion or absorption.

12Ecological information

Ecological Information: No data available. Expected readily biodegradable (peptides and amino acids), not bioaccumulative.

13Disposal considerations

Disposal Guidance: No data available.

14Transport information

Transport Classification

Note: Not regulated as a dangerous good for transport by road (DOT 49 CFR), air (IATA/ICAO) or sea (IMDG). Not a marine pollutant. Ship refrigerated or frozen as required by Section 7; the coolant (dry ice, UN 1845) is regulated when used.

15Regulatory information

Regulatory Information

Tsca: Not listed
Carcinogen Listings: Not listed
Dea: Not a controlled substance
Other: Not FDA-approved in the United States (DrugBank: investigational). Animal-derived (porcine) material - include a biological-origin statement; porcine tissue is not a BSE/TSE-relevant species but note origin for import/shipping. Not WADA-prohibited.

Carcinogen Listings

No data available.

16Other information

Revision: October 3, 2026
Sources Consulted: EVER Neuro Pharma

DrugBank DB16599

AquaPhoenix Scientific

Sigma-Aldrich

Sigma-Aldrich / Supelco

MilliporeSigma

Sigma-Aldrich BVBA

Aldrich

American Regent - Sterile Water for Injection, USP

Hospira/Pfizer - Bacteriostatic Water for Injection
Confidence: low
Additional Information: Derived from animal tissue or human urine. Sourced and processed to minimise adventitious-agent risk; handle with standard biological precautions.

Porcine brain-derived peptide and amino acid preparation; not a single substance.

Back to SDS list